Reactions

Reactions

Reactions

When science hits the headlines, we seek the views of expert sources who assess the news rigorously and quickly, according to the available evidence.

Inhaled mebufotenine improves symptoms of depression in a phase 2 trial

Individualised dosing of a synthetic inhalable formulation of mebufotenine, a psychedelic substance, led to improvements in depressive symptoms compared with placebo and was well tolerated. These are the results of a phase 2 clinical trial published in the journal JAMA Psychiatry, which includes Spanish participation. According to the authors, this supports its potential as a novel, fast-acting treatment for treatment-resistant depression.

0

Serial mice cloning cannot be sustained indefinitely

Repeated cloning cannot be sustained indefinitely in mammals, according to the findings of a twenty-year study on mice conducted in Japan. Serial cloning of mice led to an accumulation of lethal DNA mutations that affected birth rates from the 27th generation onwards, with the 58th generation being the last, according to the article published in Nature Communications, showing that sexual reproduction is necessary to prevent large-scale genetic mutations.

0

UN report raises alarm over status of migratory freshwater fish, including three species found in Spain

Worldwide, 349 species of migratory freshwater fish are at risk and meet the criteria for inclusion in the Appendices of the United Nations Convention on the Conservation of Migratory Species of Wild Animals (CMS), a global treaty designed to protect migratory animals. These fish are among the vertebrates most threatened by factors such as changes in river flow, habitat degradation, exploitation and pollution, the report warns. Among the priority species are 50 species from Europe, including the following freshwater fish from Spain: Alosa alosa (shad), Lampetra planeri (brook lamprey) and Salmo salar (Atlantic salmon).

0

Researchers observe link between drought and antibiotic resistance in soil bacteria

Drought is linked to the growth of antibiotic-resistant bacteria in the soil, according to a study published in Nature Microbiology. Using data from hospitals in 116 countries, the study observes a link between local aridity and the prevalence of antibiotic-resistant bacteria, although the research does not prove a causal relationship between the two phenomena.

0

A lab-grown oesophagus has been developed and implanted in pigs

A team in the UK has developed the first laboratory-grown oesophagus in pigs that has been shown to safely replace an entire section of the organ and restore normal function, including swallowing, in a growing animal without the need for immunosuppression. The procedure, successfully carried out on eight pigs, involves removing cells from a donor organ, repopulating it with the recipient’s own cells and then implanting it. If this technology is adapted for use in humans, it could help in the treatment of newborns or children born with oesophageal atresia, a serious congenital malformation in which the oesophagus does not develop properly. The results are published in Nature Biotechnology.

0

Final blackout report by European operators confirms event was caused by multiple factors, recommends improving oversight and coordination

The European Network of Transmission System Operators for Electricity (ENTSO-E) has published its final report on the blackout of 28 April 2025 that left mainland Spain and Portugal without power. The document, drawn up by a panel of 49 members, concludes that the blackout was caused by a combination of many interacting factors, including oscillations, deficiencies in voltage control, rapid power reductions and generator disconnections in Spain. These factors caused rapid voltage rises and cascading generation disconnections, leading to the blackout. At a press briefing, Damián Cortinas, Chair of the ENTSO-E Board of Directors, clarified: “The problem is not renewable energy, but voltage control, regardless of the type of generation”. He added: “This isn’t about high technology; it’s something we’ve been able to do for decades.” Experts have made recommendations to prevent similar situations in Europe, such as strengthening operational practices, improving monitoring of system behaviour, closer coordination and data sharing among electricity system operators. Furthermore, they have highlighted the need to adapt regulatory frameworks to implement these recommendations in line with the changing nature of the electricity system.

0

The Abel Prize, the ‘Nobel Prize’ of mathematics, has been awarded to Gerd Faltings for his work on Diophantine equations

The German mathematician Gerd Faltings has won the Abel Prize, awarded by the Norwegian Academy of Science and Letters. Faltings, director emeritus of the Max Planck Institute for Mathematics, became a celebrity at the age of 29 for proving a conjecture that earned him the Fields Medal in 1986. His contributions have revolutionised arithmetic geometry, a branch of mathematics at the intersection of the two oldest: number theory and geometry.

 

0

Oral semaglutide does not slow the progression of Alzheimer's disease, according to a trial

Oral semaglutide is not effective in slowing the progression of the disease in patients with mild Alzheimer’s disease, according to the findings of the first large-scale, randomised phase 3 clinical trials published in The Lancet. In these trials, around 3,800 patients aged between 55 and 85 with a confirmed diagnosis and mild symptoms received up to 14 mg daily of oral semaglutide or a placebo. After two years, no significant difference in disease progression was observed. 

0

The poorest regions in Europe have higher mortality rates from air pollution

A study led by ISGlobal shows that European regions with higher levels of poverty and lower use of renewable energy face a greater risk of mortality from air pollution. The research, published in Nature Medicine, analysed 88.8 million deaths that occurred between 2003 and 2019 across 653 regions in 31 European countries, covering a population of 521 million people. Areas with higher GDP per capita, lower poverty rates, and longer life expectancy—mainly in northern and western Europe—showed lower mortality risks, while other regions, particularly in southern Europe, experienced up to double the associated risk.

0

A study in mice and human tissue shows that the antioxidant glutathione feeds cancer cells

Glutathione is considered an antioxidant due to its ability to repair cellular damage. The body produces it naturally, but it is also sold as an antioxidant supplement. A study in mice and human tissue, published in Nature, shows that cancer cells can break it down and use it as fuel—particularly the cysteine it contains—promoting tumour growth and survival. “Depriving tumours of extracellular glutathione or inhibiting its breakdown is potentially a viable therapeutic strategy for cancer patients,” the authors state.

0